Arterial pressure, vasopressors and septic shock: Higher is not necessarily better

Critical Care Medicine

Volumn 33, Issue 4, 2005, Pages 906-907

  Reisbeck, Manuela ^a   Astiz, Mark E ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Mean arterial pressure; Organ perfusion; Septic shock

Indexed keywords

DOPAMINE; HYPERTENSIVE FACTOR; NORADRENALIN; PHENYLEPHRINE; VASOPRESSIN;

AUTOREGULATION; DRUG SAFETY; EDITORIAL; FORWARD HEART FAILURE; HEART MUSCLE ISCHEMIA; HUMAN; HYPOTENSION; INTENSIVE CARE; MEAN ARTERIAL PRESSURE; ORGAN PERFUSION; PRIORITY JOURNAL; RESUSCITATION; SEPTIC SHOCK; SIDE EFFECT; TACHYCARDIA; VASOCONSTRICTION;

DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; HYPERTENSION; HYPOTENSION; NOREPINEPHRINE; REFERENCE VALUES; SHOCK, SEPTIC; VASOCONSTRICTOR AGENTS;

EID: 17044419279     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000159695.20613.2C     Document Type: Editorial

References (15)

1. Johnson P: Autoregulation of blood flow. Circ Res 1986; 59:483-495
2. Mueller H, Ayres S, Giannelli S, et al: Effect of isoproterenol, 1-norepinephrine, and intraaortic counterpulsation on hemodynamics and myocardial metabolism in shock following acute myocardial infarction. Circ 1972; 16:335-350
3. Strandgaard S, Sengupta E, MacKenzie E, et al: The lower and upper limits of autoregulation of cerebral blood flow. In Cerebral circulation and Metabolism. Langfitt T et al (Eds). New York, Springer-Verlag, 1975, pp 3-6
4. Hayes MA, Timmins AC, Yau E, et al: Elevation of systemic oxygen delivery in the treatment of critically ill patients. N Engl J Med 1994; 330:1717-1722
5. Desjars P, Pinaud M, Bugnon D, et al: Norepinephrine therapy has no deleterious renal effects in human septic shock. Crit Care Med 1989; 17:426-429
6. Martin C, Eon B, Akin P, et al: Renal effects of norepinephrine used to treat septic shock. Crit Care Med 1990; 18:282-285
7. Ledoux D, Astiz M, Carpati C, et al: Effects of perfusion pressure on tissue perfusion in septic shock. Crit Care Med 2000; 28:2729-2732
8. Bourgoin A, Leone M, Delmas A, et al: Increasing mean arterial pressure in patients with septic shock: Effects on oxygen variables and renal function. Crit Care Med 2005; 33:780-786
9. Marik P, Mohedin M: The contrasting effects of dopamine and norepinephrine on systemic and splanchnic oxygen utilization in hyperdynamic sepsis. JAMA 1994; 272:1354-1357
10. Neviere R, Mathieu D, Chagnon JL, et al: The contrasting effects of dobutamine and dopamine on gastric mucosal perfusion in septic patients. Am J Respir Crit Care Med 1996; 154:1684-1688
11. Matta B, Stow P: Sepsis-induced vasoparalysis does not involve the cerebral vasculature: Indirect evidence from autoregulation and carbon dioxide reactivity studies. Br J Anesth 1996; 76:790-794
12. Tristani F, Cohn J: Studies in clinical shock and hypotension. VI. Renal hemodynamics before and during treatment. Circulation 1970; 52:839-851
13. Gunnar R, Cruz A, Boswell J, et al: Myocardial infarction with shock. Hemodynamic studies and results of therapy. Circulation 1966; 32:753-762
14. Mueller H, Evans R, Ayres S: Effect of dopamine on hemodynamics and myocardial metabolism in shock following myocardial infarction in man. Circulation 1978; 57:361-365
15. Landry D, Levin H, Gallant E, et al: Vasopressin deficiency contributes to vasodilation of septic shock. Circulation 1997; 95:1122-1125